✨ Your Portfolio is fetched and updated from zerodha.
Nano Chemicals
Market Cap
₹359 Cr.
P/E
33.62

Key Ratios

Market cap
Market cap
359 Cr
PE
PE
33.62
Prom Holding
Prom Holding
70.76 %
ROE (%)
ROE (%)
0.91
ROCE (%)
ROCE (%)
0.84
Div Yield (%)
Div Yield (%)
2.64
Sales
Sales
26.72 Cr
OPM (%)
OPM (%)
41.34 %
Debt to Equity
Debt to Equity
-
Institutions
Institutions
1.76 %
Individual < 2 lac
Individual < 2 lac
21.34 %
No. of Shareholders
No. of Shareholders
14,913

About

Naperol Investments Ltd. is a Mumbai-based investment and leasing company of the Wadia Group. … Read more
Low
490
52W Range
High
1212
  • Naperol Investments
  • Alufluoride
  • Evexia Lifecare
  • TJI Chemicals

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

Edit rows

Forensics

7 Yes

Positive for this company

1 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

33 %
(as of Mar 19)
Hydrogen Peroxide - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Capacity Utilization - Hydrogen Peroxide (%)
    • Manufacturing Capacity - Hydrogen Peroxide (MTPA)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Naperol Investments Ltd. Business

    Naperol Investments Ltd. is a Mumbai-based investment and leasing company of the Wadia Group. Formerly known as National Peroxide Ltd., it transitioned from specialty chemicals to investment-focused operations following a business restructuring in 2023.

    Naperol Investments major competitors are Alufluoride, Evexia Lifecare, Narmada Gelatines, A-1, Andhra Petrochem, Mangalam Organics, Hind Organic Chem.
    Market Cap of Naperol Investments is ₹359 Crs.
    While the median market cap of its peers are ₹348 Crs.

    Naperol Investments seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material